AF
MDT icon

Abound Financial’s Medtronic MDT Stock Holding History

Abound Financial’s Portfolio MDT Stock Details MDT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$6.67K Hold
77
– – ﹤0.01% 226
2025
Q4 		$7.4K Buy
+77
New +$7.48K ﹤0.01% 220
2025
Q2 		– Sell
-77
Closed -$6.92K – 182
2025
Q1 		$6.92K Buy
+77
New +$6.89K ﹤0.01% 217

Other funds holding MDT

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
Massachusetts Financial Services
Massachusetts Financial Services Boston, Massachusetts $298B AUM 21.96% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Abound Financial's MDT Position: Q1 2026 in Review

Abound Financial held its Medtronic (MDT) position steady in Q1 2026 at 77 shares worth $6.67K. The position accounts for ﹤0.01% of the portfolio, ranked #226.

Abound Financial first reported a position in MDT in Q1 2025 and has held it in 3 quarters since. The position peaked at $7.4K in Q4 2025. 2,229 funds tracked by Wall St. Rank hold MDT as of Q1 2026.

  • Abound Financial held 77 shares of Medtronic worth $6.67K as of Q1 2026.
  • Abound Financial left its Medtronic share count unchanged in Q1 2026.
  • Medtronic made up ﹤0.01% of Abound Financial's portfolio in Q1 2026, its #226 holding.
  • Abound Financial first reported a position in Medtronic in Q1 2025 and has held it in 3 quarters since.
  • Abound Financial's Medtronic position peaked at $7.4K in Q4 2025.
  • 2,229 funds tracked by Wall St. Rank held Medtronic as of Q1 2026.

Based on Abound Financial's 13F filing for Q1 2026, filed 4 May 2026.